ATHE Reports Positive FDA Feedback on ATH434 Phase 3 CMC Alignment, End-of-Phase 2 Meeting Targets Mid-2026
Alterity Therapeutics Limited American Depositary Shares · Now $4.02
-2.2% in 7d after detection
Post-detection moves
1h
—
1d
-0.9%
3d
-1.7%
7d
-2.2%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS